Cancer stem cells: Redefining the paradigm of cancer treatment strategies

Molecular Interventions

Volumn 6, Issue 3, 2006, Pages 140-148

  Dean, Michael ^a,b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b Human Genetics Section   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER INHIBITOR; ANTINEOPLASTIC AGENT; CYCLOPAMINE; GAMMA SECRETASE INHIBITOR; RAPAMYCIN; UNCLASSIFIED DRUG;

ASBESTOSIS; BREAST CANCER; CANCER RESEARCH; CANCER RISK; CANCER STEM CELL; CANCER THERAPY; CELL ACTIVATION; CELL ISOLATION; CELL POPULATION; DRUG INHIBITION; DRUG SYNTHESIS; EMBRYO CELL; HORMONE ACTION; HUMAN; NONHUMAN; ORGAN DISTRIBUTION; REVIEW; SMOKING; TISSUE INJURY;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MODELS, BIOLOGICAL; MUTATION; NEOPLASMS; RISK FACTORS; STEM CELLS;

EID: 33745712636     PISSN: 15340384     EISSN: None     Source Type: Journal    
DOI: 10.1124/mi.6.3.5     Document Type: Review

References (64)

1. Mintz, B. and Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 72, 3585-3589 (1975).
2. Hamburger, A.W. and Salmon, S.E. Primary bioassay of human tumor stem cells. Science 197, 461-463 (1977). Review of tumor suppressor genes proving three classifications of tumors and the relevance of stem cells.
3. Knudson, A.G. Antioncogenes and human cancer. Proc. Natl. Acad. Sci. U.S.A. 90, 10914-10921 (1993).
4. Lapidot, T., C. Sirard, J. Vormoor et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994). The first isolation of leukemia stem cells.
5. Dean, M. Towards a unified model of tumor suppression: Lessons learned from the human patched gene. Biochim. Biophys. Acta 1332, M43-M52 (1997). Review of the role of the PTCH gene in cancer and the inovolvement of PTCH in the stimulation of skin stem cells.
6. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., and Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100, 3983-3988 (2003). The first isolation of cancer stem cells in a solid tumor.
7. Hemmati, H.D., Nakano, I, Lazareff, J.A., Masterman-Smith, M., Geschwind, D.H., Bronner-Fraser, M., and Kornblum, H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U.S.A. 100, 15178-15183 (2003).
8. Kondo, T., Setoguchi, T., and Taga, T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. U.S.A. 101, 781-786 (2004).
9. Hirschmann-Jax, C., Foster, A.E., Wulf, G.G., Nuchtern, J.G., Jax, T.W., Gobel, U., Goodell, M.A., and Brenner, M.K. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. U.S.A. 101, 14228-14233 (2004).
10. Thomlinson, R.H. and Gray, L.H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer 9, 539-549 (1955).
11. Zhou, S., Schuetz, J.D., Bunting, K.D. et al. The ABC transporter Bcrp1/ ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat. Med. 7, 1028-1034 (2001).
12. Scharenberg, C.W., Harkey, M.A., and Torok-Storb, B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 99, 507-512 (2002).
13. Kim, M., Turnquist, H., Jackson, J., Sgagias, M., Yan, Y., Gong, M., Dean, M., Sharp, J.G., and Cowan, K. The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells. Clin. Cancer Res. 8, 22-28 (2002).
14. Till, J.E., McCulloch, E.A., and Siminovitch, L. A stochastic model of stem cell proliferation, based on the growth of spleen colony-forming cells. Proc. Natl. Acad. Sci. U.S.A. 51, 29-36 (1964).
15. Rizvi, A.Z., Swain, J.R., Davies, P.S., Bailey, A.S., Decker, A.D., Willenbring, H., Grompe, M., Fleming, W.H., and Wong, M.H. Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc. Natl. Acad. Sci. U.S.A. 103, 6321-6325 (2006).
16. Beachy, P.A., Karhadkar, S.S., and Berman, D.M. Tissue repair and stem cell renewal in carcinogenesis. Nature 432, 324-331 (2004). Review article on the importance of tissue damage to the initiation of cancer.
17. Tennant, R. What is a tumor promoter? Environ. Health Perspect. 107, A390-A391 (1999).
18. Knudson, A.G., Mutation and cancer: Statistical study of retinoblastoma. Proc. Natl. Acad. Sci. U.S.A. 68, 820-823 (1971).
19. Trichopoulos, D., Lagiou, P., and Adami, H.O. Towards an integrated model for breast cancer etiology: the crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res. 7, 13-17 (2005).
20. Gail, M.H., Brinton, L.A., Byar, D.P., Corle, D.K., Green, S.B., Schairer, C., and Mulvihill, J.J. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J. Natl. Cancer Inst. 81, 1879-1886 (1989).
21. Kauff, N.D., Satagopan, J.M., Robson. M.E. et al. Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. N. Engl. J. Med. 346, 1609-1615 (2002).
22. Eaden, J. Colorectal carcinoma and inflammatory bowel disease. Aliment. Pharmacol. Ther. 20 Suppl 4, 24-30 (2004).
23. Gardner, E.J. Follow-up study of a family group exhibiting dominant inheritance for a syndrome including intestinal polyps, osteomas, fibromas and epidermal cysts. Am. J. Hum. Genet. 14, 376-390 (1962).
24. Nishisho, I., Nakamura, Y., Miyoshi, Y. et al. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253, 665-669 (1991).
25. Groden, J. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66, 589-600 (1991).
26. Deschner, E.E. and Lipkin, M. Proliferative patterns in colonic mucosa in familial polyposis. Cancer 35, 413-418 (1975).
27. Su, L.K., Kinzler, K.W., Vogelstein, B., Preisinger, A.C., Moser, A.R., Luongo, C., Gould, K.A., and Dove, W.F. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256, 668-670 (1992).
28. Moser, A.R., Dove, W.F., Roth, K.A., and Gordon, J.I. The Min (multiple intestinal neoplasia) mutation: Its effect on gut epithelial cell differentiation and interaction with a modifier system. J. Cell Biol. 116, 1517-1526 (1992).
29. Kinzler, K.W. and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).
30. Beasley, R.P., Hwang, L.Y., Lin, C.C., and Chien, C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2, 1129-1133 (1981).
31. Yu, M.C., Tong, M.J., Coursaget, P., Ross, R.K., Govindarajan, S., and Henderson, B.E. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma in the United States. J. Natl. Cancer Inst. 82, 1038-1041 (1990).
32. Hughes, J. and Weil, H. Epidemiology of Lung Cancer, in Lung Biology in Health and Disease, J. Samet, Editor. 1994, Marcel Dekker: New York. pp. 185-205.
33. Knudson, A. Asbestos and mesothelioma: Genetic lessons from a tragedy. Proc. Natl. Acad. Sci. U.S.A. 92, 10819-10820 (1995).
34. Wu-Williams, A.H., Yu, M.C., and Mack, T.M. Life-style, workplace, and stomach cancer by subsite in young men of Los Angeles County. Cancer Res. 50, 2569-2576 (1990).
35. Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., and Schlemper, R.J. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345, 784-789 (2001).
36. Michaud, D.S., Epidemiology of pancreatic cancer. Minerva Chir. 59, 99-111 (2004).
37. zur Hausen, H., Meinhof, W., Scheiber, W., and Bornkamm, G.W. Attempts to detect virus-secific DNA in human tumors. I. Nucleic acid hybridizations with complementary RNA of human wart virus. Int. J. Cancer 13, 650-656 (1974).
38. Werness, B.A., Levine, A.J., and Howley, P.M. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science 248, 76-79 (1990).
39. Tommasino, M. and Crawford, L. Human papillomavirus E6 and E7: Proteins which deregulate the cell cycle. Bioessays 17, 509-518 (1995).
40. Tindle, R.W. Immune evasion in human papillomavirus-associated cervical cancer. Nat. Rev. Cancer 2, 59-65 (2002).
41. Sasadeusz, J., Kelly, H., Szer, J., Schwarer, A.P., Mitchell, H., and Grigg, A. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transplant 28, 393-397 (2001).
42. Millward, M.J., Cantwell, B.M., Munro, N.C., Robinson, A., Corris, P.A., and Harris, A.L. Oral verapamil with chemotherapy for advanced nonsmall cell lung cancer: A randomised study. Br. J. Cancer 67, 1031-1035 (1993).
43. Alley, M.C., Scudiero, D.A., Monks, A. et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res. 48, 589-601 (1988).
44. Nakachi, K., Hayashi, T., Imai, K., and Kusunoki, Y. Perspectives on cancer immuno-epidemiology. Cancer Sci. 95, 921-929 (2004).
45. Folkman, J. Role of angiogenesis in tumor growth and metastasis. Semin. Oncol. 29, 15-18 (2002).
46. Yilmaz, O.H., Valdez, R., Theisen, B.K., Guo, W., Ferguson, D.O., Wu, H., and Morrison, S.J. Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells. Nature 441, 475-482 (2006). Demonstration of distinct properties of cancer stem cells and normal stem cells and a potential cancer stem cell-specific therapy.
47. Gottesman, M.M., Fojo, T., and Bates, S.E. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat. Rev. Cancer 2, 48-58 (2002).
48. Goodell, M.A., Brose, K., Paradis, G., Conner, A.S., and Mulligan, R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183, 1797-1806 (1996).
49. Dean, M., Fojo, T., and Bates, S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 5, 275-284 (2005). Review on the implications of cancer stem cells to chemotherapy resistance.
50. Dean, M. and Annilo, T. Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates. Ann. Rev. Hum. Genet. Genom. 6, 123-142 2005.
51. Henrich, C.J., Bokesch, H.R., Dean, M., Bates, S.E., Robey, R.W., Goncharova, E.I., Wilson, J.A., and McMahon, J.B. A high-throughput cell-based assay for inhibitors of ABCG2 activity. J. Biomol. Screen. 11, 176-183 (2006).
52. Nusslein-Volhard, C. and Wieschaus, E. Mutations affecting segment number and polarity in Drosophila. Nature 287, 795-801 (1980).
53. Hahn, H., Wicking, C., Zaphiropoulous, P.G. et al. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85, 841-851 (1996). This article and the following one demonstrated that the PTCH gene is responsible for the inherited nevoid basal cell carcinoma and established PTCH as a tumor suppressor gene.
54. Johnson, R.L., Rothman, A.L., Xie, J. et al. Human homolog of patched, a candidate gene for the Basal Cell Nevus Syndrome. Science 272, 1668-1671 (1996).
55. Bale, A.E. and Yu, K.P. The hedgehog pathway and basal cell carcinomas. Hum. Mol. Genet. 10, 757-762 (2001).
56. Berman, D.M., Karhadkar, S.S., Maitra, A. et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 425, 846-851 (2003). Paper implicating the Hedgehog pathway in several cancers and presenting pre-clinical data on the use of cyclopamine in cancer therapy.
57. Watkins, D.N., Berman, D.M., Burkholder, S.G., Wang, B., Beachy, P.A., and Baylin, S.B. Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422, 313-317 (2003).
58. Thayer, S.P., di Magliano, M.P., Heiser, P.W. et al. Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature 425, 851-856 (2003).
59. Karhadkar, S.S., Bova, G.S., Abdallah, N., Dhara, S., Gardner, D., Maitra, A., Isaacs, J.T., Berman, D.M., and Beachy, P.A. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 431, 707-712 (2004).
60. James, L.F., Panter, K.E., Gaffield, W., and Molyneux, R.J. Biomedical applications of poisonous plant research. J. Agric. Food Chem. 52, 3211-3230 (2004).
61. Chen, J.K., Taipale, J., Cooper, M.K., and Beachy, P.A. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev. 16, 2743-2748 (2002).
62. Athar, M., Li, C., Tang, X., et al. Inhibition of smoothened signaling prevents ultraviolet B-induced basal cell carcinomas through regulation of Fas expression and apoptosis. Cancer Res. 64, 7545-7552 (2004).
63. +/- mice. Proc. Natl. Acad. Sci. U.S.A. 98, 10320-10325 (2001).
64. Recher, C., Dos Santos, C., Demur, C., and Payrastre, B. mTOR, a new therapeutic target in acute myeloid leukemia. Cell Cycle 4, 1540-1549 (2005).